Dr. David Reza Oveisi, MD

  • West Hollywood, CA
  • Hematologist and oncologist
NPI1386006369PAC ID9234483322
Medicare services, 2024
720
Medicare patients, 2024
187
Part D claims, 2024
768
Publications
3
Clinical trials
1
Practice address
8700 Beverly Blvd, Los Angeles, CA 90048
Practice phone
Call (310) 423-5000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Cedars-Sinai Medical Center

Hospital · Los Angeles, California

Find Dr. Oveisi's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. David Reza Oveisi is a hematologist and oncologist in West Hollywood, California

Dr. Oveisi practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Oveisi's NPI, 1386006369, was assigned on March 28, 2016. Dr. Oveisi graduated from Uconn School Of Medicine in 2016. Dr. Oveisi holds California license A154795.

NPI and contact details
Medicare PAC ID
9234483322
NPI enumeration date
March 28, 2016
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(310) 423-5000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
36
Medical school graduation
2016

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. David Reza Oveisi practices at Cedars-Sinai Medical Center in Los Angeles, California

Dr. Oveisi's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Source: Dmand AI Affiliation Data

Dr. David Reza Oveisi is affiliated with 1 site of care and 1 medical group

Dr. Oveisi's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center.

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. David Reza Oveisi's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Oveisi practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Cedars-Sinai Medical CenterAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Oveisi practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Cedars-Sinai Health System and 6.2K+ hospitals, with verified contacts in the same login.

Dr. David Reza Oveisi is one of 1,502 hematologists and oncologists in California

Hematology and oncology is Dr. Oveisi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Oveisi is board certified in hematology by the American Board of Internal Medicine. Dr. Oveisi is licensed in California.

Specialties and state licenses

  • Hematology and oncology, CaliforniaPrimaryLicense A154795 · 2018 to 2026 · taxonomy 207RH0003X

Clinical focus

Dmand AI lists breast cancer, chronic anemia, deep vein thrombosis (DVT), multiple myeloma, neutropenia and purpura and thrombocytopenia among the conditions Dr. Oveisi treats.

Hematologists and oncologists near Dr. Oveisi

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. David Reza Oveisi billed Medicare for 720 services in 2024

CMS data shows 720 Medicare services from Dr. Oveisi across 7 procedure codes in 2024, for 187 Medicare patients. Medicare paid $72,234 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2024720
Medicare patients187
Paid by Medicare$72,234
Procedure codes7

Dr. Oveisi's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 6432024: 72012%

Dr. Oveisi compared with the California median for hematologists and oncologists, 2024

  • Dr. Oveisi
  • California median
Medicare services
720vs 93223% below
Medicare patients
187vs 22517% below
Part D claims
618vs 39457% above

Medians across 1,367 hematologists and oncologists in California with Dmand AI profiles that report each measure.

Dr. Oveisi's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Oveisi

Need commercial claims for Dr. Oveisi?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Oveisi and other hematologists and oncologists in California.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. David Reza Oveisi treated 187 Medicare patients in 2024, average age 71

CMS counts 187 Medicare patients who saw Dr. Oveisi in 2024. The largest group is 65 to 74, with 84 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 40% are also on Medicaid. Their average risk score is 3.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Oveisi's median patient age at 69, with 44% women.

Medicare patients, 2024187
Average age71
Average risk score3.40
Also on Medicaid40%

Dr. Oveisi's Medicare patients by age, 2024

Dr. Oveisi's Medicare patients by sex, 2024

  • Women8747%
  • Men10053%

Chronic conditions among Dr. Oveisi's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol73%
  3. Chronic kidney disease55%
  4. Arthritis51%
  5. Ischemic heart disease47%
  6. Diabetes39%
  7. Heart failure36%
  8. Mood disorders29%

Share of Medicare patients with each condition. A patient can have several.

Dr. Oveisi's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women44%
  • Men55%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. David Reza Oveisi wrote 768 Medicare Part D claims in 2024

In 2024, Dr. Oveisi wrote 768 Medicare Part D claims for 92 patients. 81% of them were for generic drugs. CMS names the drug for 618 of them, across 18 drugs with 11 or more claims each, at $2,098,863 in total drug cost. In 2023, CMS named 312 claims across 14 drugs.

Part D claims, 2024768
Drugs named by CMS18
Total drug cost$2.1M
Part D patients92

Dr. Oveisi's Part D claims by kind of drug, 2024

  • Generic625 claims81%
  • Brand-name143 claims19%

Dr. Oveisi's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Oveisi's Part D claims, 2024

  • Opioids6%46 of 768 claims
  • Antibiotics7%52 of 768 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 3122024: 61898%

Drugs named by CMS: 18 in 2024, 14 in 2023.

See all prescribing by Dr. Oveisi

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. David Reza Oveisi scored 93 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Oveisi for performance year 2024, reported as part of a group. Dr. Oveisi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Oveisi as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Oveisi's MIPS scores, performance year 2024

  • 93of 100Final score
  • 77.8of 100Quality
  • 98of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 71of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Oveisi by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. David Reza Oveisi has 3 publications on record

Dmand AI links 3 papers to Dr. Oveisi, published from 2016 to 2022. Dr. Oveisi's most frequent co-authors are Vincent J. Cheung, MD, Monica Safwat El-Masry, MD and Christina Nahed Fanous, DO.

Papers3
Years published2016 to 2022

Dr. Oveisi's papers by year, 2016 to 2022

Dr. Oveisi's most frequent co-authors

Recent publications by Dr. Oveisi

See all 3 publications and co-authors

See who Dr. Oveisi researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Oveisi works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. David Reza Oveisi has worked on 1 clinical trial

Dmand AI links Dr. Oveisi to 1 clinical trial. Conditions studied include Multiple Myeloma and Blood Protein Disorders. Open Payments lists research payments to Dr. Oveisi that name 1 trial.

Conditions in Dr. Oveisi's trials

  • Multiple Myeloma
  • Blood Protein Disorders

Investigators on the most trials with Dr. Oveisi

Recent clinical trials with Dr. Oveisi

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. David Reza Oveisi received $38,764 in industry payments from 2019 to 2025

CMS Open Payments shows 89 general payments to Dr. Oveisi from 17 drug and device companies from 2019 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Janssen Pharmaceuticals, Inc paid the most, $27,546. It also lists 3 research payments totaling $93 in 2024, naming 1 clinical trial.

General payments to Dr. Oveisi by program year, 2019 to 2025

General payments to Dr. Oveisi by kind, 2019 to 2025

$38.8Kin total
  • Speaker and faculty fees$25,46866%
  • Consulting fees$8,21021%
  • Food and beverage$4,06910%
  • Travel and lodging$8432%
  • Education$1740%

Companies that paid Dr. Oveisi the most, 2019 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Oveisi

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. David Reza Oveisi has 1 award and honors on record

Dmand AI lists 1 award for Dr. Oveisi, most recently Chief Fellow, Hematology and Oncology in 2022. Dr. Oveisi serves on Data Safety and Monitoring Committee.

Awards and honors for Dr. Oveisi

  1. 2022
    • Chief Fellow, Hematology and Oncology

Dr. Oveisi's committees and leadership roles

Data Safety and Monitoring CommitteeMember
2023 to present

Source: Dmand AI Professional Profile Data

Dr. David Reza Oveisi graduated from Uconn School Of Medicine

Dr. Oveisi graduated from Uconn School Of Medicine in 2016. Dr. Oveisi is a member of ACP, ASCO, ASH and International Myeloma Society.

  1. Medical schoolUconn School Of Medicine
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in internal medicineAmerican Board of Internal Medicine
  4. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. David Reza Oveisi accepts plans from 13 insurance carriers

Dr. Oveisi is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

  • Aetna
  • Blue Cross Blue Shield of Michigan
  • Elevance
  • United Healthcare
  • HCSC
  • Blue Cross Blue Shield of Massachusetts
  • Regence Health Plans
  • Alliant Health Plans
  • +5 more carriersWith a free account

Plan types Dr. Oveisi accepts, by number of carriers

  1. PPO9
  2. Medicare7
  3. HMO6
  4. EPO4
  5. POS4

Source: Dmand AI Insurance Network Data

Sources for Dr. David Reza Oveisi's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. David Reza Oveisi

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. David Reza Oveisi's NPI number?

Dr. David Reza Oveisi's NPI number is 1386006369. It was assigned on March 28, 2016, and it is active in the NPI Registry.

What kind of doctor is Dr. David Reza Oveisi?

Dr. David Reza Oveisi is a hematologist and oncologist in West Hollywood, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. David Reza Oveisi practice?

Dr. Oveisi practices at 8700 Beverly Blvd, Los Angeles, CA 90048. Dr. Oveisi's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

What is Dr. David Reza Oveisi's office phone number?

The practice phone on file for Dr. Oveisi is (310) 423-5000.

What is Dr. David Reza Oveisi's medical license number?

Dr. Oveisi holds California license A154795.

Which hospitals is Dr. David Reza Oveisi affiliated with?

Dr. Oveisi practices at Cedars-Sinai Medical Center in Los Angeles, California.

What medical group is Dr. David Reza Oveisi part of?

Dr. Oveisi is linked to Cedars-Sinai Medical Center.

Does Dr. David Reza Oveisi accept Medicare?

Yes. CMS data shows Dr. Oveisi billed Medicare for 720 services in 2024, and Dr. Oveisi accepts Medicare assignment.

Does Dr. David Reza Oveisi offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Oveisi as offering telehealth services.

What is Dr. David Reza Oveisi's MIPS score?

Dr. Oveisi's MIPS final score for performance year 2024 is 93 out of 100, reported as part of a group.

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. David Reza Oveisi see?

CMS counts 187 Medicare patients who saw Dr. Oveisi in 2024, with an average age of 71.

Is Dr. David Reza Oveisi board certified?

Yes. Dr. Oveisi is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. David Reza Oveisi bill to Medicare?

In 2024, Dr. Oveisi's most billed Medicare services were office visit, established patient (99214), hospital inpatient care (99233) and hospital inpatient care (99223).

Where did Dr. David Reza Oveisi go to medical school?

Dr. Oveisi graduated from Uconn School Of Medicine in 2016.

What drugs does Dr. David Reza Oveisi prescribe most?

In 2024 Medicare Part D data, Dr. Oveisi's most prescribed drugs by claims were Valacyclovir, Dexamethasone and Lenalidomide.

Has Dr. David Reza Oveisi received payments from drug or device companies?

CMS Open Payments shows $38,764 in general payments to Dr. Oveisi from 17 companies from 2019 to 2025. The largest total came from Janssen Pharmaceuticals, Inc.

How long has Dr. David Reza Oveisi been practicing?

Dr. Oveisi graduated from medical school in 2016, 10 years ago.

Does Dr. David Reza Oveisi do research?

Dmand AI links 3 publications to Dr. Oveisi, published from 2016 to 2022. Dr. Oveisi has worked on 1 clinical trial.

Who does Dr. David Reza Oveisi publish with?

Dr. Oveisi's most frequent co-authors are Vincent J. Cheung, MD (1 shared paper), Monica Safwat El-Masry, MD (1 shared paper) and Christina Nahed Fanous, DO (1 shared paper).

What insurance does Dr. David Reza Oveisi accept?

Dr. Oveisi is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in California by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)